Company · CIK 0001740547 · SIC 2834 — Pharmaceutical Preparations
Urovant Sciences Ltd. · UROV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2018 PForm 4 → | Oct 3, 7:18 pm EDT | Andrew Lo10% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 5:58 pm EDT | Dexxon Holdings Ltd. +210% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 5:56 pm EDT | VIKING GLOBAL INVESTORS LP +610% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 5:52 pm EDT | VIKING GLOBAL PERFORMANCE LLC +510% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 5:50 pm EDT | QVT Associates GP LLC +110% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 5:47 pm EDT | SVF Investments (UK) Ltd +310% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 4:49 pm EDT | Patrick Machado10% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
| Oct 1, 2018 PForm 4 → | Oct 3, 4:48 pm EDT | Roivant Sciences Ltd.10% Owner | 2,678,571 | $14.00 | $37,499,994 | 22,703,669 | +13.4% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 AForm 4 → | Mar 5, 8:44 pm EST | James A. Robinson Jr.Director | 50,000 | — | — | 50,000 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:24 pm EST | Michael E. McFaddenCCO/Urovant Sciences, Inc. | 100,000 | — | — | 100,000 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:23 pm EST | Bryan E. SmithGC/Urovant Sciences, Inc. | 70,000 | — | — | 70,000 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:22 pm EST | Keith KatkinPEO;CEO/Urovant Sciences, Inc., Director | 350,250 | — | — | 350,250 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:22 pm EST | Christine OcampoPFAO;CAO/Urovant Sciences, Inc | 70,000 | — | — | 70,000 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:21 pm EST | Cornelia Haag-MolkentellerCMO/Urovant Sciences, Inc. | 100,000 | — | — | 100,000 | — | |
| Jan 6, 2019 AForm 4 → | Jan 8, 5:20 pm EST | Nori EbersoleSVP;CHRO/Urovant Sciences, Inc | 65,000 | — | — | 65,000 | — | |
| Nov 21, 2018 AForm 4 → | Nov 26, 8:40 pm EST | Frank TortiDirector | 50,000 | — | — | 50,000 | — | |
| Nov 21, 2018 AForm 4 → | Nov 26, 8:40 pm EST | Myrtle S PotterDirector | 50,000 | — | — | 50,000 | — | |
| Nov 21, 2018 AForm 4 → | Nov 26, 8:38 pm EST | Pierre LegaultDirector | 36,650 | — | — | 36,650 | — | |
| Nov 21, 2018 AForm 4 → | Nov 26, 8:37 pm EST | Sef KurstjensDirector | 36,650 | — | — | 36,650 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:12 pm EDT | Keith KatkinPEO;CEO-Urovant Sciences,Inc., Director | 99,967 | — | — | 99,967 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:11 pm EDT | Nori EbersoleSVP&CHRO-Urovant Sciences,Inc. | 3,000 | — | — | 3,000 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:10 pm EDT | Bryan E. SmithGC of Urovant Sciences,Inc. | 3,500 | — | — | 3,500 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:09 pm EDT | Cornelia Haag-MolkentellerCMO of Urovant Sciences, Inc. | 1,000 | — | — | 1,000 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:08 pm EDT | Michael E. McFaddenCCO of Urovant Sciences, Inc. | 4,750 | — | — | 4,750 | — | |
| Oct 15, 2018 AForm 4 → | Oct 17, 6:07 pm EDT | Christine OcampoPFAO;CAO/Urovant Sciences,Inc. | 3,750 | — | — | 3,750 | — | |
| Oct 1, 2018 AForm 4 → | Oct 3, 9:04 pm EDT | Keith KatkinPEO;CEO-Urovant Sciences,Inc., Director | 200,250 | — | — | 200,250 | — | |
| Sep 26, 2018 AForm 4 → | Sep 28, 4:10 pm EDT | Keith KatkinPEO;CEO-Urovant Sciences,Inc., Director | 39,815 | — | — | 39,815 | — |